Legal status · Australia
Is GW0742 legal in Australia?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. GW0742 is not an approved medicine in Australia; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, no human study is cited on its profile.
GW0742 in Australia at a glance
| Classification | Not approved |
|---|---|
| Note | Not approved; prohibited in sport. |
| TGA approval status | Not approved by TGA |
| Human studies cited | 0 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the GW0742 profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
No product containing GW0742 is approved by TGA for any use in Australia, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.
What GW0742 is
The sibling of GW501516, sold on the same endurance story with none of the same evidence. No human study of GW0742 of any design has ever been published, and the endurance result is mice on a treadmill.
GW0742 is a selective agonist at PPAR-beta/delta, the same nuclear receptor GW501516 targets, from the same GlaxoSmithKline chemistry. It is sold in the research chemical market as the newer, cleaner cardarine.
Mechanism: Selective agonism at PPAR-beta/delta, a nuclear receptor that upregulates fatty acid oxidation and mitochondrial genes in skeletal muscle. In the mouse combination study, GW0742-treated groups tended to higher PGC-1alpha protein, and at exhaustion Pgc1a, Pdk4, Cd36 and Lpl were upregulated in muscle, with a measurable shift from carbohydrate to fat as the fuel and glycogen sparing that delayed hypoglycaemia.
Regulatory history: Never approved and never tested in a registered human trial. Prohibited in sport by WADA alongside the rest of the PPAR-delta agonist class.
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for GW0742 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
GW0742 in other countries
Frequently asked questions
Is GW0742 legal in Australia?
No. GW0742 is not an approved medicine in Australia; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, no human study is cited on its profile. Note: Not approved; prohibited in sport.
Can I buy GW0742 in Australia?
No approved product exists to buy. In Australia GW0742 is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Not approved; prohibited in sport.
Is GW0742 TGA approved?
No. In Australia GW0742 is classified as "Not approved", which is not a TGA marketing approval. For comparison, the US FDA status is: Never approved and never tested in a registered human trial. Prohibited in sport by WADA alongside the rest of the PPAR-delta agonist class.. On the evidence, no human study is cited on its profile.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for GW0742 live on its compound profile.
GW0742 profileThis page is general information about the regulatory status of GW0742 in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.